Methods of treating cancer by administering EMP2 antibodies
US9011857B2 · kind B2 · utility
0Cited by
28References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 26, 2012 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Nov 26, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions useful in the treatment or prevention of Chlamydia infections and cancer. The methods and compositions inhibit the entry of Chlamydia into a host cell expressing EMP2 by interfering with the interaction between the Chlamydia and EMP2. The methods and compositions target cancers which express or overexpress EMP2 nucleic acids and polypeptides by targeting EMP2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.